January 2024

Jan 16

Reflow Medical Receives CE Mark for Bare Temporary Spur Stent System for Treating de novo or Restenotic Below-the-Knee (BTK) Lesions

By Reflow Medical Announcement, Press Releases

San Clemente, CA—Jan. 15, 2024 – Reflow Medical, Inc., a developer of innovative medical devices focused on cardiovascular disease, announces it has received CE (Conformité Européenne) Mark certification in the…

©2024 Reflow Medical, Inc. All rights reserved. Reflow Medical, Wingman, Spex, coraForce, coraCross, coraFlex, Spur, and The Pulse of Medical Ingenuity are registered trademarks or trademarks of Reflow Medical, Inc. This device is restricted to use by or on the order of a physician. Federal law (USA) restricts these devices to sale by or on the order of a physician. Refer to the Instructions for Use for a complete listing of the Indications, Contraindications, Warnings, Precautions, Complications/Adverse Events, and Directions for Use/Procedural Steps. WEB-0001 Rev C

January 2024

Reflow Medical Receives CE Mark for Bare Temporary Spur Stent System for Treating de novo or Restenotic Below-the-Knee (BTK) Lesions

Recent Posts

Recent Comments

Archives

Categories

Meta

COMPANY

PRODUCTS

CLINICAL

Corporate Address

January 2024

Reflow Medical Receives CE Mark for Bare Temporary Spur Stent System for Treating de novo or Restenotic Below-the-Knee (BTK) Lesions

Recent Posts

Recent Comments

Archives

Categories

Meta

COMPANY

DISCLAIMER

PRODUCTS

CLINICAL

Corporate Address